Table 1.
Baseline characteristics of patients with hepatocellular carcinoma
| Characteristics | All patients (n = 94) | MVI | P value | |
|---|---|---|---|---|
| Negative (n = 56) | Positive (n = 38) | |||
| Gender | 0.217 | |||
| Male | 88 (93.6%) | 54 (57.4%) | 34 (36.2%) | |
| Female | 6 (6.4%) | 2 (2.1%) | 4 (4.3%) | |
| Age, years (range) | 52 ± 11 (24–75) | 52 ± 10 (30–73) | 53 ± 12 (24–75) | 0.744 |
| Diameter, cm (range) | 1.9 ± 0.8 (1.2–4.5) | 1.8 ± 0.8 (1.2–3.5) | 2.2 ± 0.7 (1.4–4.5) | 0.078 |
| Etiology | 0.190 | |||
| HBV | 87 (92.6%) | 54 (57.4%) | 33 (35.1%) | |
| HCV | 5 (5.3%) | 1 (1.1%) | 4 (4.2%) | |
| Alcohol or none | 2 (2.1%) | 1 (1.1%) | 1 (1.1%) | |
| Presence of cirrhosis | 0.754 | |||
| Presence | 66 (70.2%) | 40 (42.6%) | 26 (27.7%) | |
| Absence | 28 (29.8%) | 16 (17.0%) | 12 (12.7%) | |
| Edmondson-Steiner grade | 0.380 | |||
| I-II | 57 (60.6%) | 36 (38.3%) | 21 (22.3%) | |
| III-IV | 37 (39.4%) | 20 (21.3%) | 17 (18.1%) | |
| AFP > 20 ng/ml | > 0.99 | |||
| Positive | 51 (54.3%) | 30 (31.9%) | 21 (22.3%) | |
| Negative | 43 (45.7%) | 26 (27.7%) | 17 (18.1%) | |
| Child-Pugh | > 0.99 | |||
| A | 91 (96.8%) | 54 (57.4%) | 37 (39.4%) | |
| B | 3 (3.2%) | 2 (2.1%) | 1 (1.1%) | |
HBV Hepatitis B virus, HCV Hepatitis C virus, AFP a-fetoprotein, MVI Microvascular invasion